Table 1.
Characteristics | HCC (aN = 30) | ||
---|---|---|---|
Age | Mean (SD) | 61.67 (12.2) | |
Gender | Male | 83.33% | |
Race | AA | 30% | |
EA | 37% | ||
Asian | 33% | ||
BMI | Mean (SD) | 26.17 (5.4) | |
Smoking | Yes | 66.67% | |
No | 33.33% | ||
Alcohol | Yes | 47% | |
No | 53% | ||
HCV Serology | HCV Ab+ | Reactive | 37% |
HCV Ab+ | Non-Reactive | 60% | |
HCV Ab+ | Unavailable | 3.33% | |
HCV RNA+ | Reactive | 16.67% | |
HCV RNA+ | Non-Reactive | 17% | |
HCV RNA+ | Unavailable | 63% | |
HBV Serology | anti HBC+ | Reactive | 10% |
anti HBC+ | Non-Reactive | 3.33% | |
anti HBC+ | Unavailable | 87% | |
HBs Ag+ | Reactive | 17% | |
HBs Ag+ | Non-Reactive | 70% | |
HBs Ag+ | Unavailable | 13% | |
MELD | Mean (SD) | 10.04 (4.5) | |
MELD < 10 | 56.67% | ||
AFP (ng/mL) | Median (IQR) | 4.4 (14.05) | |
Child Pugh Score | Mean (SD) | 6.14 (1.5) | |
Median (IQR) | 6 (1) | ||
Child Pugh Class | A | 73% | |
B | 13.33% | ||
C | 3.33% | ||
AST (IU/L) | Median (IQR) | 123 (158) | |
ALT (IU/L) | Median (IQR) | 117 (152) | |
HCC Stage (TNM Staging) |
Stage I | 43% | |
Stage II | 24% | ||
Stage III & IV | 33% |
aAdjacent normal tissue for the HCC patients are available for this study